Symbiotec Pharmalab Ltd

NSE: SYMBIOTEC | BSE: 544889

₹1,198.00

up-down-arrow ₹21.25 (1.81%)

As on 01-Oct-2026IST

Market cap

info icon

₹7,706 Cr

Revenue (TTM)

info icon

₹869 Cr

P/E Ratio

info icon

70.1

P/B Ratio

info icon

5.1

Div. Yield

info icon

0 %

Value Research Rating

Quality Score fund-quick-summary-circle

Quality Score5/10

Growth Score fund-quick-summary-circle

Growth Score8/10

Valuation Score fund-quick-summary-circle

Valuation Score4/10

Momentum Score fund-quick-summary-circle

Momentum ScoreUNRATED/10

Symbiotec Pharmalab Share Price

Compare

High: Low: Return:

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 1,161.10 High: 1,246.00

52 Week Range

Low: 934.20 High: 1,246.00

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹110 Cr

  • ROEROE information

    11.2 %

  • ROCEROCE information

    12.4 %

  • Industry P/EIndustry P/E information

    56.89

  • EV/EBITDAEV/EBITDA information

    33.4

  • Debt to EquityDebt to Equity information

    0.3

  • Book ValueBook Value information

    ₹183.2

  • EPSEPS information

    ₹17.5

  • Face valueFace value information

    2

  • Shares outstandingShares outstanding information

    64,256,112

8 Years Aggregate

CFO

₹625.60 Cr

EBITDA

₹868.98 Cr

Net Profit

₹443.47 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Symbiotec Pharmalab
-- 21.3 -- -- -- -- --
BSE Sensex
-15.1 -6.6 -6.0 -10.4 3.0 4.0 9.9
BSE Healthcare
14.9 -3.2 1.2 15.8 20.5 13.8 11.9
As on 01-Oct-2026
The underlying data is unavailable.

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Symbiotec Pharmalab
1,198.0 7,706.2 869.2 109.9 -- 11.2 70.1 5.1
1,374.2 16,849.2 2,590.4 603.0 29.3 19.6 27.9 4.8
541.8 10,259.7 885.7 234.9 27.8 18 43.7 4.6
1,374.1 14,385.3 1,108.4 270.2 28.3 14.5 52.2 6.9
1,944.6 36,872.2 9,683.5 1,019.0 15.7 21.3 36.5 7.0
133.7 7,326.1 1,950.6 140.6 7.6 9.6 52.1 5.6
21,505.0 27,579.5 2,371.8 497.8 28.0 28.5 55.4 13.6
990.0 5,937.9 942.6 9.9 0.3 1.2 685.2 3.8
1,199.8 13,556.1 675.6 183.6 32.2 22.7 74.2 14.7
308.3 8,717.1 8.8 -352.4 -4,228.0 -80.8 -- 15.7

Shareholding Pattern

View Details
loading...

News & Analysis

All News

About Symbiotec Pharmalab

--

  • Incorporated

    2002

  • Chairman

    Anil Satwani

  • Managing Director

    Anil Satwani

  • Headquarters

    Indore, Madhya Pradesh

  • Website

    www.symbiotec.com

FAQs for Symbiotec Pharmalab

The share price of Symbiotec Pharmalab Ltd is ₹1,198.00 (NSE) and ₹1,199.30 (BSE) as of 01-Oct-2026 IST. Symbiotec Pharmalab Ltd has given a return of --% in the last 1 years.

The P/E ratio of Symbiotec Pharmalab Ltd is 70.12 times as on 01-Oct-2026, a 23 premium to its peers’ median range of 56.89 times.
The P/B ratio of Symbiotec Pharmalab Ltd is 5.14 times as on 01-Oct-2026, a 4 premium to its peers’ median range of 4.95 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2026
0.00
0.00
2025
0.00
0.00
2024
0.00
0.00
2023
0.00
0.00
2022
0.00
0.00

The 52-week high and low of Symbiotec Pharmalab Ltd are Rs 1,246.00 and Rs 934.20 as of 01-Oct-2026.

Symbiotec Pharmalab Ltd has a market capitalisation of ₹ 7,706 Cr as on 01-Oct-2026. As per SEBI classification, it is a company.

Before investing in Symbiotec Pharmalab Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...